MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$7,793K
(29.80%↑ Y/Y)
Diagnostic Tests
$22,291K
(36.62%↑ Y/Y)
Development Services
$3,264K
(98.78%↑ Y/Y)
Loss from operations
-$6,201K
(32.13%↑ Y/Y)
Total other expense
-$1,592K
(18.98%↑ Y/Y)
Revenues
$25,555K
(42.30%↑ Y/Y)
Other income, net
$385K
(292.86%↑ Y/Y)
Total operating
expenses
$31,756K
(17.21%↑ Y/Y)
Interest expense
$1,977K
(17.33%↑ Y/Y)
Sales, marketing,
general and...
$24,261K
(18.65%↑ Y/Y)
Direct costs and
expenses
$4,205K
(13.56%↑ Y/Y)
Research and development
$3,285K
(14.46%↑ Y/Y)
Impairment loss on
intangible assets
$5K
(-93.15%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BIODESIX INC (BDSX)
BIODESIX INC (BDSX)